Puma Biotechnology (PBYI) Research & Development (2012 - 2026)
Puma Biotechnology (PBYI) posted Research & Development of $19.8 million for Q1 2026, up 17.54% on a QoQ basis from $16.8 million in Q4 2025, and up 42.79% year-over-year from $13.9 million in Q1 2025.
Puma Biotechnology (PBYI) Research & Development (2012 - 2026) Analysis & Trends
Puma Biotechnology's Research & Development history runs 15 years deep, the most recent figure standing at $19.8 million for Q1 2026.
- Quarterly Research & Development rose 42.79% year-over-year to $19.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $68.0 million (up 23.16% YoY) and the FY2025 annual result came in at $62.1 million, up 12.98% from the prior year.
- Research & Development was $19.8 million for Q1 2026 at Puma Biotechnology, up from $16.8 million in the prior quarter.
- Across five years, Research & Development topped out at $19.8 million in Q1 2026 and bottomed at $7.0 million in Q3 2022.
- A 5-year average of $13.8 million and a median of $13.6 million in 2024 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2022 — Research & Development tumbled 62.84% — and 2023, when it soared 63.51%.
- Puma Biotechnology's Research & Development stood at $13.8 million in 2022, then slipped by 6.61% to $12.9 million in 2023, then rose by 17.84% to $15.2 million in 2024, then grew by 11.02% to $16.8 million in 2025, then grew by 17.54% to $19.8 million in 2026.
- Business Quant data shows PBYI's Research & Development at $19.8 million in Q1 2026, $16.8 million in Q4 2025, and $15.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 541.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -2.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.37 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 343.97 Mn |
| 10 | Puma Biotechnology | 407.27 Mn | 368.99 Mn | 34.39 Mn | 19.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.80 Mn |
| Dec 31, 2025 | 16.84 Mn |
| Sep 30, 2025 | 15.91 Mn |
| Jun 30, 2025 | 15.45 Mn |
| Mar 31, 2025 | 13.86 Mn |
| Dec 31, 2024 | 15.17 Mn |
| Sep 30, 2024 | 12.55 Mn |
| Jun 30, 2024 | 13.63 Mn |
| Mar 31, 2024 | 13.59 Mn |
| Dec 31, 2023 | 12.87 Mn |
| Sep 30, 2023 | 11.45 Mn |
| Jun 30, 2023 | 13.36 Mn |
| Mar 31, 2023 | 12.71 Mn |
| Dec 31, 2022 | 13.78 Mn |
| Sep 30, 2022 | 7.00 Mn |
| Jun 30, 2022 | 11.97 Mn |
| Mar 31, 2022 | 15.24 Mn |
| Dec 31, 2021 | 14.17 Mn |
| Sep 30, 2021 | 18.84 Mn |
| Jun 30, 2021 | 18.64 Mn |